Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2310666120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Douwe J Dijkstra und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands. Hauptthemen laut MEDLINE: Autoimmune Diseases, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EC | ERC | HORIZON EUROPE European Research Council (ERC), Leids Universitair Medisch Centrum (LUMC).
Abstract (Originalsprache)
Autoantibodies directed against complement component C1q are commonly associated with autoimmune diseases, especially systemic lupus erythematosus. Importantly, these anti-C1q autoantibodies are specific for ligand-bound, solid-phase C1q and do not bind to fluid-phase C1q. In patients with anti-C1q, C1q levels are in the normal range, and the autoantibodies are thus not depleting. To study these human anti-C1q autoantibodies at the molecular level, we isolated C1q-reactive B cells and recombinantly produced nine monoclonal antibodies (mAbs) from four different healthy individuals. The isolated mAbs were of the IgG isotype, contained extensively mutated variable domains, and showed high affinity to the collagen-like region of C1q. The anti-C1q mAbs exclusively bound solid-phase C1q in complex with its natural ligands, including immobilized or antigen-bound IgG, IgM or CRP, and necrotic cells. Competition experiments reveal that at least 2 epitopes, also targeted by anti-C1q antibodies in sera from SLE patients, are recognized. Electron microscopy with hexameric IgG-C1q immune complexes demonstrated that multiple mAbs can interact with a single C1q molecule and identified the region of C1q targeted by these mAbs. The opsonization of immune complexes with anti-C1q greatly enhanced Fc-receptor-mediated phagocytosis but did not increase complement activation. We conclude that human anti-C1q autoantibodies specifically bind neo-epitopes on solid-phase C1q, which results in an increase in Fc-receptor-mediated effector functions that may potentially contribute to autoimmune disease immunopathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands.
- Lava Therapeutics, Utrecht 3584 CM, The Netherlands.
- Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands.
- Department of Rheumatology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands.
- Department of Medical Microbiology, University Medical Center, Utrecht 3584 CX, The Netherlands.
- Sanquin Diagnostic Services, Amsterdam 1066 CX, The Netherlands.
ORCID-Profile: Douwe J Dijkstra, Leoni Abendstein, Cynthia S M Kramer, Jan W Drijfhout, Lisanne de Vor, Kyra A Gelderman, Suzan H M Rooijakkers, Arnaud Zaldumbide, Gestur Vidarsson, Thomas H Sharp, Paul W H I Parren, Leendert A Trouw
Förderung
- EC | ERC | HORIZON EUROPE European Research Council (ERC)
- Leids Universitair Medisch Centrum (LUMC)
Zitieren
APA
Dijkstra, D. J., van de Bovenkamp, F. S., Abendstein, L., Zuijderduijn, R., Pool, J., Kramer, C. S. M., Slot, L. M., Drijfhout, J. W., de Vor, L., Gelderman, K. A., Rooijakkers, S. H. M., Zaldumbide, A., Vidarsson, G., Sharp, T. H., Parren, P. W. H. I., & Trouw, L. A. (2023). Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2310666120
Vancouver
Dijkstra DJ, van de Bovenkamp FS, Abendstein L, Zuijderduijn R, Pool J, Kramer CSM, et al. Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2310666120
BibTeX
@article{Dijkstra2023,
author = {Dijkstra, Douwe J and van de Bovenkamp, Fleur S and Abendstein, Leoni and Zuijderduijn, Rob and Pool, Jos and Kramer, Cynthia S M and Slot, Linda M and Drijfhout, Jan W and de Vor, Lisanne and Gelderman, Kyra A and Rooijakkers, Suzan H M and Zaldumbide, Arnaud and Vidarsson, Gestur and Sharp, Thomas H and Parren, Paul W H I and Trouw, Leendert A},
title = {Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2310666120}
}
EUVIMED